AirLife is removing Broselow Rainbow Tapes due to incorrectly printed medication dosing information.
Similar Posts
Biosimilars | Science and Research
Learn about FDA’s latest in biosimilar science and research.Aerosol and Liquid Packaging, Inc. – 676746 – 07/24/2024
CGMP/Finished Pharmaceuticals/AdulteratedResources for Biomarker Requestors
Information and resources for requestors about FDA’s Biomarker Qualification ProgramThe Center for Research on Complex Generics
FDA awards a 5-year grant to the University of Maryland and the University of Michigan to establish a Center for Research on Complex Generics (CRCG).Fusion IV Pharmaceuticals Inc. dba Axia Pharmaceuticals, Los Angeles, CA. Amended 483 Issued 03/23/2017
Fusion IV Pharmaceuticals Inc. dba Axia Pharmaceuticals, Los Angeles, CA. Amended 483 Issued 03/23/2017Task Description Request Please post to the 2017 Pharmacy Inspections and Related Records Web page
Record Date 03/23/2017
FEI Number 3013341563
Firm Name Fusion IV Pharmaceuticals Inc. dba Axia PSexual Enhancement and Energy Product Notifications
Learn about the warnings for sexual enhancement and energy products that contain hidden drugs and other hidden ingredients.